An international team of researchers identified two biomarkers that were good at predicting a patient's resistance to radiation therapy for squamous cell cancer of the head and neck.
Big data analytics has predicted if a patient is suffering from aggressive triple-negative breast cancer, slower-moving cancers, or noncancerous lesions with 95% accuracy.
Good nutritional status, quality of life, and satisfaction with eating seen at 10 years post-esophagectomy.
Long-term use of valproic acid (VPA) is associated with a reduced risk of smoking-related cancers of the head and neck, according to a study.
For head and neck cancer patients undergoing radiation therapy, a reduction in the amount of radiation treatment volume to the submandibular (level IB) lymph nodes resulted in better patient-reported salivary function.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|